Prescribing Information Medication Guide Healthcare Professional Site Sign Up Facebook icon Instagram icon
What is Lems
About Firdapse
How Firdapse Works Results with Firdapse Side Effects of Firdapse
Starting Firdapse
Taking Firdapse Access and Affordability
Support & Resources
Patient Support Patient Ambassadors LEMS Physician Locator News & Events FAQs
Patient Stories
Sign Up
Facebook icon Facebook
Instagram icon Instagram

RESULTS WITH FIRDAPSE

FIRDAPSE improved muscle strength and patients’ perception of their own physical well-being

In two separate Phase 3 clinical trials, clinical studies conducted with patients. FIRDAPSE was tested against a placebo an inactive medication in patients with Lambert-Eaton myasthenic syndrome (LEMS).

The two Phase 3 studies were designed as withdrawal trials*:

Trial design graphic: All patients began the trial taking FIRDAPSE; Half the patients were randomized to continue with FIRDAPSE or transitioned to placebo; Patients in the placebo group transitioned back to FIRDAPSE before the study end.
Trial design graphic: All patients began the trial taking FIRDAPSE; Half the patients were randomized to continue with FIRDAPSE or transitioned to placebo; Patients in the placebo group transitioned back to FIRDAPSE before the study end.

*Withdrawal trials are used when researchers want to minimize the use of a placebo for ethical or feasibility reasons, and/or in situations where the efficacy can be determined immediately after patients stop taking the medication being studied.

RESULTS 

The patients who started and stayed on FIRDAPSE:

  • Experienced less muscle weakness†
  • Reported feeling better about their physical well-being‡

† Measured by Quantitative Myasthenia Gravis (QMG) score, an objective assessment of arm strength, leg strength, face and neck muscle performance, swallowing, speech, grip strength, forced breathing, gaze impairment, and other measures.

‡   Measured by Subject Global Impression (SGI) score, a patient-reported outcome measure that shows how much they improved with FIRDAPSE compared to the placebo.

FIRDAPSE improved functional mobility

FIRDAPSE was evaluated in a separate test, the Triple-Timed Up-and-Go (3TUG), which measured how well FIRDAPSE improved the ability of LEMS patients to walk and move.

3TUG TEST 

1. Stand without using arms. 2. Walk 3m. 3. Turn around 180 degrees. 4. Walk back. 5. Sit down. 6. Repeat 2 more times.
1. Stand without using arms. 2. Walk 3m. 3. Turn around 180 degrees. 4. Walk back. 5. Sit down. 6. Repeat 2 more times.

The 3TUG is a simple, timed test that requires the patient to stand up from a straight-backed armchair, walk 3 meters, turn around and walk back, and sit back down in the chair.

Individuals perform these actions 3 consecutive times without pause. The final measurement is the average time it takes the patient to complete all 3 repetitions.

RESULTS 

The patients who received FIRDAPSE took significantly less time to complete the test compared to patients who received the placebo.

NEXT: FIRDAPSE Safety and Side Effects
Check icon

IS IT LEMS?

Your symptoms may be trying to tell you something. Take a brief assessment survey to get a better picture of what’s really going on, and then share it with your doctor.
Take the Assessment
FIRDAPSE Education Brochure

Educational Brochure

Download an educational brochure about LEMS and how FIRDAPSE may help.
Download Now

We'd love to hear from you!

Ready to take a short survey (3–5 minutes) to tell us more about you and your experience on our website?

Catalyst Pharmaceuticals respects your personal health information. The information you provide may be used to send you relevant health-related materials and to develop products, services, and programs for the communities that we serve. Catalyst Pharmaceuticals or third parties working on our behalf will not sell or rent personal health information. Your information will only be used in accordance with the Catalyst Privacy Policy.

If you later wish to opt out of receiving this information, you may click on the included opt-out link in future communications.

By completing this registration, you confirm that you are 18 years of age or older and a US resident.

THANK YOU!

We’ll be in touch soon.

What is FIRDAPSE®?

FIRDAPSE is a prescription medicine used to treat adults 17 years of age or older with Lambert-Eaton myasthenic syndrome (LEMS). The safety and efficacy of FIRDAPSE in patients under the age of 17 has not been established.

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about FIRDAPSE?

  • FIRDAPSE can cause seizures.
    • You could have a seizure even if you never had a seizure before.
    • Do not take FIRDAPSE if you have ever had a seizure.

Stop taking FIRDAPSE and call your doctor right away if you have a seizure while taking FIRDAPSE.

Do not take FIRDAPSE if you:

  • have ever had a seizure.
  • are allergic to amifampridine phosphate, or another aminopyridine.

Before you take FIRDAPSE, tell your doctor about all of your medical conditions, including if you:

  • are taking another aminopyridine, such as compounded 3,4-diaminopyridine (3,4-DAP)
  • have had a seizure
  • have kidney problems
  • have liver problems
  • are pregnant or plan to become pregnant. It is not known if FIRDAPSE will harm your unborn baby. You and your doctor will decide if you should take FIRDAPSE while you are pregnant.
  • There is a registry for women who become pregnant during treatment with FIRDAPSE. The purpose of this registry is to collect information about your health and your baby’s health. Contact the registry as soon as you learn that you are pregnant, or ask your healthcare provider to contact for you by calling 855-212-5856 (toll free), contacting the Fax number 877-867-1874 (toll free), emailing the Pregnancy Coordinating Center at firdapsepregnancyregistry@ubc.com, or visiting the study website www.firdapsepregnancystudy.com.
  • are breastfeeding or plan to breastfeed. It is not known if FIRDAPSE passes into your breast milk. Talk to your doctor about the best way to feed your baby while taking FIRDAPSE.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How should I take FIRDAPSE?

  • Take FIRDAPSE exactly as your doctor tells you to take it. Do not change your dose of FIRDAPSE.
  • Do not take more than 2 tablets of FIRDAPSE at one time or more than 8 tablets of FIRDAPSE in a 24-hour period.
  • FIRDAPSE can be taken with or without food.
  • If you miss a dose of FIRDAPSE, skip that dose and take your next dose at your next scheduled dose time. Do not double your dose to make up the missed dose.
  • Do not take FIRDAPSE together with other medicines known to increase the risk of seizures.
  • If you take too much FIRDAPSE, call your doctor or go to the nearest hospital emergency room right away.

What are the possible side effects of FIRDAPSE?

FIRDAPSE may cause serious side effects, including:

  • Seizures. See "What is the most important information I should know about FIRDAPSE?"
  • Serious allergic reactions, such as anaphylaxis. FIRDAPSE can cause serious allergic reactions. Stop taking FIRDAPSE and call your doctor right away or get emergency medical help if you have:
    • shortness of breath or trouble breathing
    • swelling of your throat or tongue
    • ­hives
  • The most common side effects of FIRDAPSE include:
    • tingling around the mouth, tongue, face, fingers, toes, and other body parts
    • upper respiratory infection
    • stomach pain
    • nausea
    • diarrhea
    • headache
    • increased liver enzymes
    • back pain
    • high blood pressure
    • muscle spasms

Tell your doctor if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of FIRDAPSE.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store FIRDAPSE?

  • Store FIRDAPSE at 68ºF to 77ºF (20ºC to 25ºC).
  • Safely throw away FIRDAPSE that is out of date or no longer needed.

Keep FIRDAPSE and all medicines out of the reach of children.

If you would like more information, ask your doctor or pharmacist for additional information about FIRDAPSE.

The active ingredient in FIRDAPSE is amifampridine phosphate. Inactive ingredients are calcium stearate, colloidal silicon dioxide, and microcrystalline cellulose.

Please see full Prescribing Information for additional Important Safety Information.

What is FIRDAPSE®?

FIRDAPSE is a prescription medicine used to treat adults 17 years of age or older with Lambert-Eaton myasthenic syndrome (LEMS). The safety and efficacy of FIRDAPSE in patients under the age of 17 has not been established.

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about FIRDAPSE?

  • FIRDAPSE can cause seizures.
    • You could have a seizure even if you never had a seizure before.
    • Do not take FIRDAPSE if you have ever had a seizure.

Stop taking FIRDAPSE and call your doctor right away if you have a seizure while taking FIRDAPSE.

Do not take FIRDAPSE if you:

  • have ever had a seizure.
  • are allergic to amifampridine phosphate, or another aminopyridine.

Before you take FIRDAPSE, tell your doctor about all of your medical conditions, including if you:

  • are taking another aminopyridine, such as compounded 3,4-diaminopyridine (3,4-DAP)
  • have had a seizure
  • have kidney problems
  • have liver problems
  • are pregnant or plan to become pregnant. It is not known if FIRDAPSE will harm your unborn baby. You and your doctor will decide if you should take FIRDAPSE while you are pregnant.
  • There is a registry for women who become pregnant during treatment with FIRDAPSE. The purpose of this registry is to collect information about your health and your baby’s health. Contact the registry as soon as you learn that you are pregnant, or ask your healthcare provider to contact for you by calling 855-212-5856 (toll free), contacting the Fax number 877-867-1874 (toll free), emailing the Pregnancy Coordinating Center at firdapsepregnancyregistry@ubc.com, or visiting the study website www.firdapsepregnancystudy.com.
  • are breastfeeding or plan to breastfeed. It is not known if FIRDAPSE passes into your breast milk. Talk to your doctor about the best way to feed your baby while taking FIRDAPSE.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How should I take FIRDAPSE?

  • Take FIRDAPSE exactly as your doctor tells you to take it. Do not change your dose of FIRDAPSE.
  • Do not take more than 2 tablets of FIRDAPSE at one time or more than 8 tablets of FIRDAPSE in a 24-hour period.
  • FIRDAPSE can be taken with or without food.
  • If you miss a dose of FIRDAPSE, skip that dose and take your next dose at your next scheduled dose time. Do not double your dose to make up the missed dose.
  • Do not take FIRDAPSE together with other medicines known to increase the risk of seizures.
  • If you take too much FIRDAPSE, call your doctor or go to the nearest hospital emergency room right away.

What are the possible side effects of FIRDAPSE?

FIRDAPSE may cause serious side effects, including:

  • Seizures. See "What is the most important information I should know about FIRDAPSE?"
  • Serious allergic reactions, such as anaphylaxis. FIRDAPSE can cause serious allergic reactions. Stop taking FIRDAPSE and call your doctor right away or get emergency medical help if you have:
    • shortness of breath or trouble breathing
    • swelling of your throat or tongue
    • ­hives
  • The most common side effects of FIRDAPSE include:
    • tingling around the mouth, tongue, face, fingers, toes, and other body parts
    • upper respiratory infection
    • stomach pain
    • nausea
    • diarrhea
    • headache
    • increased liver enzymes
    • back pain
    • high blood pressure
    • muscle spasms

Tell your doctor if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of FIRDAPSE.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store FIRDAPSE?

  • Store FIRDAPSE at 68ºF to 77ºF (20ºC to 25ºC).
  • Safely throw away FIRDAPSE that is out of date or no longer needed.

Keep FIRDAPSE and all medicines out of the reach of children.

If you would like more information, ask your doctor or pharmacist for additional information about FIRDAPSE.

The active ingredient in FIRDAPSE is amifampridine phosphate. Inactive ingredients are calcium stearate, colloidal silicon dioxide, and microcrystalline cellulose.

Please see full Prescribing Information for additional Important Safety Information.

Continue Cancel